APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic Medicine for Infants and Young Children

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antipyretic Medicine for Infants and Young Children Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchAntipyretic Medicine for Infants and Young Children Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic Medicine for Infants and Young Children Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Antipyretic Medicine for Infants and Young Children Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic Medicine for Infants and Young Children Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic Medicine for Infants and Young Children Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Antipyretic Medicine for Infants and Young Children market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Antipyretic Medicine for Infants and Young Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antipyretic Medicine for Infants and Young Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antipyretic Medicine for Infants and Young Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antipyretic Medicine for Infants and Young Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antipyretic Medicine for Infants and Young Children include Anqiu Lu'an, Atabay, Farmson, Granules Biocause, Granules India, IOLCP, Mallinckrodt, Novacyl and SKPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Antipyretic Medicine for Infants and Young Children market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antipyretic Medicine for Infants and Young Children and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antipyretic Medicine for Infants and Young Children revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Antipyretic Medicine for Infants and Young Children market size, projected growth trends, production technologies, key applications, and end-use industries.

Antipyretic Medicine for Infants and Young Children Segment by Company

Anqiu Lu'an

Atabay

Farmson

Granules Biocause

Granules India

IOLCP

Mallinckrodt

Novacyl

SKPL

Strides Shasun

Temad

Anhui BBCA Likang

Anhui Fubore

Hebei Jiheng

Xinhua Pharmaceutical

Zhejiang Kangle

Antipyretic Medicine for Infants and Young Children Segment by Type

Acetaminophen

Ibuprofen

Other

Antipyretic Medicine for Infants and Young Children Segment by Application

Online Sales

Offline Sales

Antipyretic Medicine for Infants and Young Children Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic Medicine for Infants and Young Children market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic Medicine for Infants and Young Children and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic Medicine for Infants and Young Children.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Antipyretic Medicine for Infants and Young Children in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antipyretic Medicine for Infants and Young Children industry.

Chapter 3: Detailed analysis of Antipyretic Medicine for Infants and Young Children companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antipyretic Medicine for Infants and Young Childrenrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Acetaminophen Table 3. Key Players of Ibuprofen Table 4. Key Players of Other Table 4. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Online Sales Table 6. Key Players of Offline Sales Table 7. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2021-2026) Table 10. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2027-2032) Table 12. Antipyretic Medicine for Infants and Young Children Industry Trends Table 13. Antipyretic Medicine for Infants and Young Children Industry Drivers Table 14. Antipyretic Medicine for Infants and Young Children Industry Opportunities and Challenges Table 15. Antipyretic Medicine for Infants and Young Children Industry Restraints Table 16. Global Antipyretic Medicine for Infants and Young Children Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Company (2021-2026) Table 18. Global Antipyretic Medicine for Infants and Young Children Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Antipyretic Medicine for Infants and Young Children Key Company Head Office and Area Served Table 20. Global Antipyretic Medicine for Infants and Young Children Company, Product Type & Application Table 21. Global Antipyretic Medicine for Infants and Young Children Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Antipyretic Medicine for Infants and Young Children by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Antipyretic Medicine for Infants and Young Children Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Type (2021-2026) Table 28. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Type (2027-2032) Table 29. Global Antipyretic Medicine for Infants and Young Children Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Application (2021-2026) Table 33. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Application (2027-2032) Table 34. Anqiu Lu'an Company Information Table 35. Anqiu Lu'an Business Overview Table 36. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product Portfolio Table 38. Anqiu Lu'an Recent Development Table 39. Atabay Company Information Table 40. Atabay Business Overview Table 41. Atabay Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Atabay Antipyretic Medicine for Infants and Young Children Product Portfolio Table 43. Atabay Recent Development Table 44. Farmson Company Information Table 45. Farmson Business Overview Table 46. Farmson Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Farmson Antipyretic Medicine for Infants and Young Children Product Portfolio Table 48. Farmson Recent Development Table 49. Granules Biocause Company Information Table 50. Granules Biocause Business Overview Table 51. Granules Biocause Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Granules Biocause Antipyretic Medicine for Infants and Young Children Product Portfolio Table 53. Granules Biocause Recent Development Table 54. Granules India Company Information Table 55. Granules India Business Overview Table 56. Granules India Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Granules India Antipyretic Medicine for Infants and Young Children Product Portfolio Table 58. Granules India Recent Development Table 59. IOLCP Company Information Table 60. IOLCP Business Overview Table 61. IOLCP Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. IOLCP Antipyretic Medicine for Infants and Young Children Product Portfolio Table 63. IOLCP Recent Development Table 64. Mallinckrodt Company Information Table 65. Mallinckrodt Business Overview Table 66. Mallinckrodt Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Mallinckrodt Antipyretic Medicine for Infants and Young Children Product Portfolio Table 68. Mallinckrodt Recent Development Table 69. Novacyl Company Information Table 70. Novacyl Business Overview Table 71. Novacyl Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Novacyl Antipyretic Medicine for Infants and Young Children Product Portfolio Table 73. Novacyl Recent Development Table 74. SKPL Company Information Table 75. SKPL Business Overview Table 76. SKPL Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. SKPL Antipyretic Medicine for Infants and Young Children Product Portfolio Table 78. SKPL Recent Development Table 79. Strides Shasun Company Information Table 80. Strides Shasun Business Overview Table 81. Strides Shasun Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Strides Shasun Antipyretic Medicine for Infants and Young Children Product Portfolio Table 83. Strides Shasun Recent Development Table 84. Temad Company Information Table 85. Temad Business Overview Table 86. Temad Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Temad Antipyretic Medicine for Infants and Young Children Product Portfolio Table 88. Temad Recent Development Table 89. Anhui BBCA Likang Company Information Table 90. Anhui BBCA Likang Business Overview Table 91. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product Portfolio Table 93. Anhui BBCA Likang Recent Development Table 94. Anhui Fubore Company Information Table 95. Anhui Fubore Business Overview Table 96. Anhui Fubore Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Anhui Fubore Antipyretic Medicine for Infants and Young Children Product Portfolio Table 98. Anhui Fubore Recent Development Table 99. Hebei Jiheng Company Information Table 100. Hebei Jiheng Business Overview Table 101. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product Portfolio Table 103. Hebei Jiheng Recent Development Table 104. Xinhua Pharmaceutical Company Information Table 105. Xinhua Pharmaceutical Business Overview Table 106. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product Portfolio Table 108. Xinhua Pharmaceutical Recent Development Table 109. Zhejiang Kangle Company Information Table 110. Zhejiang Kangle Business Overview Table 111. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product Portfolio Table 113. Zhejiang Kangle Recent Development Table 114. North America Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & (US$ Million) Table 115. North America Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032) & (US$ Million) Table 116. North America Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & (US$ Million) Table 117. North America Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032) & (US$ Million) Table 118. North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) Table 120. North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2027-2032) Table 121. Europe Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & (US$ Million) Table 122. Europe Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032) & (US$ Million) Table 123. Europe Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & (US$ Million) Table 124. Europe Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032) & (US$ Million) Table 125. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) Table 127. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2027-2032) Table 128. China Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & (US$ Million) Table 129. China Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032) & (US$ Million) Table 130. China Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & (US$ Million) Table 131. China Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & (US$ Million) Table 133. Asia Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032) & (US$ Million) Table 134. Asia Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & (US$ Million) Table 135. Asia Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032) & (US$ Million) Table 136. Asia Antipyretic Medicine for Infants and Young Children Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) Table 138. Asia Antipyretic Medicine for Infants and Young Children Market Size by Country (2027-2032) Table 139. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & (US$ Million) Table 140. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032) & (US$ Million) Table 141. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) Table 145. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Antipyretic Medicine for Infants and Young Children Product Image Figure 2. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Antipyretic Medicine for Infants and Young Children Market Share by Type: 2025 VS 2032 Figure 4. Acetaminophen Image Figure 5. Ibuprofen Image Figure 6. Other Image Figure 7. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Antipyretic Medicine for Infants and Young Children Market Share by Application: 2025 VS 2032 Figure 9. Online Sales Image Figure 10. Offline Sales Image Figure 11. Global Antipyretic Medicine for Infants and Young Children Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 13. Global Antipyretic Medicine for Infants and Young Children Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Antipyretic Medicine for Infants and Young Children Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Antipyretic Medicine for Infants and Young Children Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Type (2021-2032) Figure 20. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Application (2021-2032) Figure 22. North America Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 23. North America Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032) Figure 24. North America Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032) Figure 25. North America Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 26. United States Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 27. Canada Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 29. Europe Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 30. Europe Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032) Figure 31. Europe Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032) Figure 32. Europe Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 33. Germany Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 34. France Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 36. Italy Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 37. Russia Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 39. China Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 40. China Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032) Figure 41. China Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032) Figure 42. Asia Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 43. Asia Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032) Figure 44. Asia Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032) Figure 45. Asia Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 46. Japan Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 50. India Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 51. Australia Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 56. Brazil Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 61. UAE Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 63. Chile Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Acetaminophen
  • Ibuprofen
  • Other
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Anqiu Lu'an
  • Atabay
  • Farmson
  • Granules Biocause
  • Granules India
  • IOLCP
  • Mallinckrodt
  • Novacyl
  • SKPL
  • Strides Shasun
  • Temad
  • Anhui BBCA Likang
  • Anhui Fubore
  • Hebei Jiheng
  • Xinhua Pharmaceutical
  • Zhejiang Kangle

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Acetaminophen
  5. 1.2.3 Ibuprofen
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Online Sales
  10. 1.3.3 Offline Sales
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Antipyretic Medicine for Infants and Young Children Growth Trends by Region
  13. 1.5.1 Global Antipyretic Medicine for Infants and Young Children Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026)
  15. 1.5.3 Antipyretic Medicine for Infants and Young Children Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Antipyretic Medicine for Infants and Young Children Market Dynamics
  1. 2.1 Antipyretic Medicine for Infants and Young Children Industry Trends
  2. 2.2 Antipyretic Medicine for Infants and Young Children Industry Drivers
  3. 2.3 Antipyretic Medicine for Infants and Young Children Industry Opportunities and Challenges
  4. 2.4 Antipyretic Medicine for Infants and Young Children Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Antipyretic Medicine for Infants and Young Children Revenue by Company (2021-2026)
  2. 3.2 Global Antipyretic Medicine for Infants and Young Children Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Antipyretic Medicine for Infants and Young Children Key Company Head office and Area Served
  4. 3.4 Global Antipyretic Medicine for Infants and Young Children Company, Product Type & Application
  5. 3.5 Global Antipyretic Medicine for Infants and Young Children Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Antipyretic Medicine for Infants and Young Children Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Antipyretic Medicine for Infants and Young Children Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Antipyretic Medicine for Infants and Young Children Tier 1, Tier 2, and Tier 3
4 Antipyretic Medicine for Infants and Young Children Market by Type
  1. 4.1 Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2032)
  3. 4.3 Global Antipyretic Medicine for Infants and Young Children Market Size Share by Type (2021-2032)
5 Antipyretic Medicine for Infants and Young Children Market by Application
  1. 5.1 Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2032)
  3. 5.3 Global Antipyretic Medicine for Infants and Young Children Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Anqiu Lu'an
  2. 6.1.1 Anqiu Lu'an Company Information
  3. 6.1.2 Anqiu Lu'an Business Overview
  4. 6.1.3 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product Portfolio
  6. 6.1.5 Anqiu Lu'an Recent Developments
  7. 6.2 Atabay
  8. 6.2.1 Atabay Company Information
  9. 6.2.2 Atabay Business Overview
  10. 6.2.3 Atabay Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Atabay Antipyretic Medicine for Infants and Young Children Product Portfolio
  12. 6.2.5 Atabay Recent Developments
  13. 6.3 Farmson
  14. 6.3.1 Farmson Company Information
  15. 6.3.2 Farmson Business Overview
  16. 6.3.3 Farmson Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Farmson Antipyretic Medicine for Infants and Young Children Product Portfolio
  18. 6.3.5 Farmson Recent Developments
  19. 6.4 Granules Biocause
  20. 6.4.1 Granules Biocause Company Information
  21. 6.4.2 Granules Biocause Business Overview
  22. 6.4.3 Granules Biocause Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Granules Biocause Antipyretic Medicine for Infants and Young Children Product Portfolio
  24. 6.4.5 Granules Biocause Recent Developments
  25. 6.5 Granules India
  26. 6.5.1 Granules India Company Information
  27. 6.5.2 Granules India Business Overview
  28. 6.5.3 Granules India Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Granules India Antipyretic Medicine for Infants and Young Children Product Portfolio
  30. 6.5.5 Granules India Recent Developments
  31. 6.6 IOLCP
  32. 6.6.1 IOLCP Company Information
  33. 6.6.2 IOLCP Business Overview
  34. 6.6.3 IOLCP Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 IOLCP Antipyretic Medicine for Infants and Young Children Product Portfolio
  36. 6.6.5 IOLCP Recent Developments
  37. 6.7 Mallinckrodt
  38. 6.7.1 Mallinckrodt Company Information
  39. 6.7.2 Mallinckrodt Business Overview
  40. 6.7.3 Mallinckrodt Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Mallinckrodt Antipyretic Medicine for Infants and Young Children Product Portfolio
  42. 6.7.5 Mallinckrodt Recent Developments
  43. 6.8 Novacyl
  44. 6.8.1 Novacyl Company Information
  45. 6.8.2 Novacyl Business Overview
  46. 6.8.3 Novacyl Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Novacyl Antipyretic Medicine for Infants and Young Children Product Portfolio
  48. 6.8.5 Novacyl Recent Developments
  49. 6.9 SKPL
  50. 6.9.1 SKPL Company Information
  51. 6.9.2 SKPL Business Overview
  52. 6.9.3 SKPL Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 SKPL Antipyretic Medicine for Infants and Young Children Product Portfolio
  54. 6.9.5 SKPL Recent Developments
  55. 6.10 Strides Shasun
  56. 6.10.1 Strides Shasun Company Information
  57. 6.10.2 Strides Shasun Business Overview
  58. 6.10.3 Strides Shasun Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Strides Shasun Antipyretic Medicine for Infants and Young Children Product Portfolio
  60. 6.10.5 Strides Shasun Recent Developments
  61. 6.11 Temad
  62. 6.11.1 Temad Company Information
  63. 6.11.2 Temad Business Overview
  64. 6.11.3 Temad Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Temad Antipyretic Medicine for Infants and Young Children Product Portfolio
  66. 6.11.5 Temad Recent Developments
  67. 6.12 Anhui BBCA Likang
  68. 6.12.1 Anhui BBCA Likang Company Information
  69. 6.12.2 Anhui BBCA Likang Business Overview
  70. 6.12.3 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product Portfolio
  72. 6.12.5 Anhui BBCA Likang Recent Developments
  73. 6.13 Anhui Fubore
  74. 6.13.1 Anhui Fubore Company Information
  75. 6.13.2 Anhui Fubore Business Overview
  76. 6.13.3 Anhui Fubore Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Anhui Fubore Antipyretic Medicine for Infants and Young Children Product Portfolio
  78. 6.13.5 Anhui Fubore Recent Developments
  79. 6.14 Hebei Jiheng
  80. 6.14.1 Hebei Jiheng Company Information
  81. 6.14.2 Hebei Jiheng Business Overview
  82. 6.14.3 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product Portfolio
  84. 6.14.5 Hebei Jiheng Recent Developments
  85. 6.15 Xinhua Pharmaceutical
  86. 6.15.1 Xinhua Pharmaceutical Company Information
  87. 6.15.2 Xinhua Pharmaceutical Business Overview
  88. 6.15.3 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product Portfolio
  90. 6.15.5 Xinhua Pharmaceutical Recent Developments
  91. 6.16 Zhejiang Kangle
  92. 6.16.1 Zhejiang Kangle Company Information
  93. 6.16.2 Zhejiang Kangle Business Overview
  94. 6.16.3 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product Portfolio
  96. 6.16.5 Zhejiang Kangle Recent Developments
7 North America
  1. 7.1 North America Antipyretic Medicine for Infants and Young Children Market Size (2021-2032)
  2. 7.2 North America Antipyretic Medicine for Infants and Young Children Market Size by Type
  3. 7.2.1 North America Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
  4. 7.2.2 North America Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032)
  5. 7.2.3 North America Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032)
  6. 7.3 North America Antipyretic Medicine for Infants and Young Children Market Size by Application
  7. 7.3.1 North America Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
  8. 7.3.2 North America Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032)
  9. 7.3.3 North America Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032)
  10. 7.4 North America Antipyretic Medicine for Infants and Young Children Market Size by Country
  11. 7.4.1 North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  13. 7.4.3 North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2027-2032)
  14. 7.4.4 North America Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Antipyretic Medicine for Infants and Young Children Market Size (2021-2032)
  2. 8.2 Europe Antipyretic Medicine for Infants and Young Children Market Size by Type
  3. 8.2.1 Europe Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
  4. 8.2.2 Europe Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032)
  5. 8.2.3 Europe Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032)
  6. 8.3 Europe Antipyretic Medicine for Infants and Young Children Market Size by Application
  7. 8.3.1 Europe Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
  8. 8.3.2 Europe Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032)
  9. 8.3.3 Europe Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032)
  10. 8.4 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country
  11. 8.4.1 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  13. 8.4.3 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2027-2032)
  14. 8.4.4 Europe Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Antipyretic Medicine for Infants and Young Children Market Size (2021-2032)
  2. 9.2 China Antipyretic Medicine for Infants and Young Children Market Size by Type
  3. 9.2.1 China Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
  4. 9.2.2 China Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032)
  5. 9.2.3 China Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032)
  6. 9.3 China Antipyretic Medicine for Infants and Young Children Market Size by Application
  7. 9.3.1 China Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
  8. 9.3.2 China Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032)
  9. 9.3.3 China Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Antipyretic Medicine for Infants and Young Children Market Size (2021-2032)
  2. 10.2 Asia Antipyretic Medicine for Infants and Young Children Market Size by Type
  3. 10.2.1 Asia Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
  4. 10.2.2 Asia Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032)
  5. 10.2.3 Asia Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032)
  6. 10.3 Asia Antipyretic Medicine for Infants and Young Children Market Size by Application
  7. 10.3.1 Asia Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
  8. 10.3.2 Asia Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032)
  9. 10.3.3 Asia Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032)
  10. 10.4 Asia Antipyretic Medicine for Infants and Young Children Market Size by Country
  11. 10.4.1 Asia Antipyretic Medicine for Infants and Young Children Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  13. 10.4.3 Asia Antipyretic Medicine for Infants and Young Children Market Size by Country (2027-2032)
  14. 10.4.4 Asia Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst